DA32 LIFE SCIENCE TECH ACQUISITION CORP. Inactive Instrument
DA32 Life Science Tech Acquisition Corp. Stock
Equities
DALS
US23312M1062
Investment Holding Companies
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Steven Kafka
CEO | Chief Executive Officer | 54 | 21-03-31 |
Chris Wolfe
DFI | Director of Finance/CFO | 44 | 21-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
E. Hrusovsky
BRD | Director/Board Member | 63 | 21-07-26 |
Keith Crandell
BRD | Director/Board Member | 63 | 21-07-26 |
Nicolas Roelofs
BRD | Director/Board Member | 66 | 21-07-26 |
Da32 Life Science Tech Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus its search for business combination targets in separate areas of the life sciences industry, including life sciences tools, diagnostics, synthetic biology, and data and analytics platforms. The Company is not engaged in any business operations and has not generated any revenue.
Sector
Investment Holding Companies
| 1st Jan change | Capi. | |
|---|---|---|
| +65.37% | 3.61B | |
| +1.60% | 1.01B | |
| +2.19% | 979M | |
| +41.91% | 872M | |
| +23.39% | 809M | |
| +1.72% | 663M | |
| +0.90% | 618M | |
| -.--% | 600M | |
| +20.79% | 547M |
